Ziekenhuis St. Jansdal

Public research footprint of Ziekenhuis St. Jansdal, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Non-small Cell Lung Cancer · Carcinoma, Non-Small-Cell Lung · KRAS G12C Lung Cancer · Uncommon EGFR Mutations

Recently updated registry entries

NCT07513376 — A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated… (Recruiting)
NCT04988295 — A Study of Amivantamab and Lazertinib in Combination With Platinum-Based Chemotherapy… (Active Not Recruiting)
NCT04928846 — A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Ziekenhuis St. Jansdal?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.